OBJECTIVES: We assessed the incidence of morbidity and bother on quality-of-life (QL) after radical retropubic prostatectomy for prostate cancer. METHODS: At least 12 months after surgery, self-reporting questionnaires were completed and returned by 368 (77.8%) of 473 eligible patients. Surgery related morbidity was evaluated by adhoc constructed questions. QL was assessed by the European Organization for Research and Treatment of Cancer QL core questionnaire (EORTC QLQ-C30). Multivariate and univariate analysis as well as regression analysis were used to assess the bother factors. RESULTS: Postoperative urinary incontinence significant enough for the patient to use some kind of protection was reported by 27.2%. After surgery, 14.2% of preoperative potent men were able to get and maintain an erection sufficient enough for sexual intercourse without any aid. Overall 10.6% of respondents had undergone surgery for anastomotic stricture and 23.6% reported on adjuvant therapy. Furthermore, 43.2% reported on fear of not being cured from cancer. Postoperative urinary incontinence and fear of not being cured were associated with significant lower global QL scores and turned out as independent predictors for global QL. In contrast, postoperative erectile dysfunction, anastomotic stricture and adjuvant therapy were not independent predictors. In addition, 82.1% would vote for surgery again. CONCLUSION: The majority of the patients would opt for surgical treatment again, although morbidity is common after radical prostatectomy and may impair QL. Particularly urinary incontinence and fear of not being cured are independent predictors for global QL after surgery. Therefore, surgical techniques with a low morbidity are requested as well as some kind of psychological support in order to cope with existential fear.
OBJECTIVES: We assessed the incidence of morbidity and bother on quality-of-life (QL) after radical retropubic prostatectomy for prostate cancer. METHODS: At least 12 months after surgery, self-reporting questionnaires were completed and returned by 368 (77.8%) of 473 eligible patients. Surgery related morbidity was evaluated by adhoc constructed questions. QL was assessed by the European Organization for Research and Treatment of Cancer QL core questionnaire (EORTC QLQ-C30). Multivariate and univariate analysis as well as regression analysis were used to assess the bother factors. RESULTS: Postoperative urinary incontinence significant enough for the patient to use some kind of protection was reported by 27.2%. After surgery, 14.2% of preoperative potent men were able to get and maintain an erection sufficient enough for sexual intercourse without any aid. Overall 10.6% of respondents had undergone surgery for anastomotic stricture and 23.6% reported on adjuvant therapy. Furthermore, 43.2% reported on fear of not being cured from cancer. Postoperative urinary incontinence and fear of not being cured were associated with significant lower global QL scores and turned out as independent predictors for global QL. In contrast, postoperative erectile dysfunction, anastomotic stricture and adjuvant therapy were not independent predictors. In addition, 82.1% would vote for surgery again. CONCLUSION: The majority of the patients would opt for surgical treatment again, although morbidity is common after radical prostatectomy and may impair QL. Particularly urinary incontinence and fear of not being cured are independent predictors for global QL after surgery. Therefore, surgical techniques with a low morbidity are requested as well as some kind of psychological support in order to cope with existential fear.
Authors: K Beattie; J Symons; S Chopra; C Yuen; R Savdie; R Thanigasalam; A M Haynes; J Matthews; P C Brenner; K Rasiah; R L Sutherland; P D Stricker Journal: J Robot Surg Date: 2012-07-26
Authors: Björn Löppenberg; Christian von Bodman; Marko Brock; Florian Roghmann; Joachim Noldus; Rein Jüri Palisaar Journal: Qual Life Res Date: 2014-06-06 Impact factor: 4.147
Authors: Paul Toren; Shabbir M H Alibhai; Andre Matthew; Michael Nesbitt; Robin Kalnin; Neil Fleshner; John Trachtenberg Journal: Can Urol Assoc J Date: 2009-12 Impact factor: 1.862
Authors: Catherine M Bender; Sandra J Engberg; Heidi S Donovan; Susan M Cohen; Martin P Houze; Margaret Q Rosenzweig; Gail A Mallory; Jacqueline Dunbar-Jacob; Susan M Sereika Journal: Oncol Nurs Forum Date: 2008-01 Impact factor: 2.172
Authors: Victor Maximilian Schuettfort; Roland Dahlem; Luis Kluth; Daniel Pfalzgraf; Clemens Rosenbaum; Tim Ludwig; Margit Fisch; Christoph-Philip Reiss Journal: World J Urol Date: 2017-07-03 Impact factor: 4.226